Device Transactions Device companies finished off 2012 raising $1.1 billion in the fourth quarter (a 40% increase over Q3’s $801 million), capping off the year with a grand total of $4 billion in fund
IN VITRO DIAGNOSTICS Mergers & Acquisitions Amgen Inc. deCode genetics EHF Amgen Inc. has acquired closely held human genetics firm deCODE genetics EHF for $415mm in cash. (Dec.) DeCODE was fo